Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

44 results about "Paravalvular leak" patented technology

Paravalvular leak is a leak around a valve replacement. A form of leaky heart valve. When someone has valve replacement surgery they have a new valve put in place.

Collapsible valve having paravalvular leak protection

A heart valve assembly (100) includes a heart valve (116), a self-expandable and collapsible stent (112), and a sealing member (114). The stent (112) includes an inflow end (120) and an outflow end (122), and surrounds and supports the heart valve (116). The sealing member (114) is connected to the inflow end (120) of the stent (112) and extends around a periphery of the stent (112). The sealing member (114) is connected to the inflow end (120) of the stent (112), overlaps a portion of the heart valve (116), and extends around an outer periphery of the stent (112).
Owner:ST JUDE MEDICAL CARDILOGY DIV INC

Paravalvular leak detection, sealing and prevention

The present invention provides a series of new percutaneous concepts of paravalvular repairs including identifying the leak location, several repair techniques and finally built-in means for leak prevention, built on percutaneous valves. A catheter-delivered device locates cavities occurring between a prosthetic valve and the wall of the body vessel where the valve is implanted, the cavities producing paravalvular leaks during diastole, the device comprising at least one of a plurality of flexible wires, the wire having attached to it a balloon, wherein the balloon is pulled by the leak through the cavity and wherein the wire then serves to mark the cavity location.
Owner:EDWARDS LIFESCI PVT

Anatomically-orientated and self-positioning transcatheter mitral valve

ActiveUS20160206424A1Easy to conformEasily orientBalloon catheterHeart valvesMitral valve stenosisParavalvular leak
Described herein is a mitral valve and systems and methods for implanting the same. The mitral valve device is designed to easily orient to and conform to the mitral orifice natural morphology. This mitral valve system may be implanted using a system of 2 guide wires that facilitate orientation of the flat portion of the stent properly with the flat portion of the mitral valve that is adjacent to the aortic valve. Additionally, the disclosed valve may have multiple mounds distributed across the outer surface of the valve / stent complex so as to prevent or reduce paravalvular leak after implantation.
Owner:CEDARS SINAI MEDICAL CENT

In-vitro performance testing system and testing method of transcatheter bicuspid valve valved stent

PendingCN107773328AAchieve hydrodynamic performanceEnables in vitro performance testingHeart valvesStationary stateIn vivo
The invention discloses an in-vitro performance testing system and testing method of a transcatheter bicuspid valve valved stent, and relates to prostheses capable of being implanted in vivo, in particular to a testing device and testing method applied to heart valve performance testing. The in-vitro performance testing system comprises a valve testing part which is internally provided with the bicuspid valve valved stent, a liquid circulation device and a monitoring device; a first testing part is a heart specimen of which the left ventricular apex is provided with a circulation inlet, and asecond testing part is a section of artificial blood vessel or a section of blood vessel specimen for sewing the tested bicuspid valve valved stent; the liquid testing device is connected with the first testing part to constitute a first testing circulating path for steady flow circulation and a second testing circulating path for simulating the ventricular beat of the human body; the liquid circulation device is connected with the second testing part to constitute a third testing circulating path which is connected with circulation lateral branches, in vitro tests of fluid mechanic performance, support fixing states, valve backflow, perivalvular leakage, and influences on surrounding important organization structures of the bicuspid valve valved stent can be achieved, and a durability experiment of the bicuspid valve valved stent is completed.
Owner:SHANGHAI TONGJI HOSPITAL

Paravalvular leak sealing mechanism

ActiveUS20160250022A1Facilitate sealing against paravalvular leakImprove sealingHeart valvesProsthetic valveProsthesis
A collapsible and expandable stent body includes a generally tubular annulus section, one or more prosthetic valve elements mounted to the stent body, and a cuff attached to the stent body. The prosthetic valve is operative to allow flow in an antegrade direction but to substantially block flow in a retrograde direction. The prosthetic heart valve may include paravalvular leak mitigation features in the form of first and second sealing members. The sealing members are attached to the cuff and extend circumferentially around an abluminal surface of the stent body. The sealing members each have an open side facing in a first axial direction and a closed side facing in an opposite second axial direction. Flow of blood in the second axial direction will tend to force blood into the sealing members and cause the sealing members to billow outwardly relative to the stent body, helping to mitigate paravalvular leak.
Owner:ST JUDE MEDICAL CARDILOGY DIV INC

Perivalvular leakage-proof transcatheter valve system and implanting method

The invention provides a transcatheter valve system. The transcatheter valve system includes a valve portion and a perivalvular leakage-proof portion independent of the valve portion. The valve portion includes a valve frame, valve leaflets, sealing skirts and sutures for suturing the valve leaflets, the valve frame and the sealing skirts together. The perivalvular leakage-proof portion is independent of the valve portion and includes a fixing portion and a sealing portion; the fixing portion is used for anchoring the perivalvular leakage-proof portion on a corresponding position of lesion in the valve; and the sealing portion is used for filling a gap due to the fact that the valve cannot be attached on a wall well after being implanted. In operation, the perivalvular leakage-proof portion is implanted in a human body, and then the valve portion is implanted in the human body; on a good-adherent part, the implanted valve can compact the sealing portion of the perivalvular leakage-proof portion; on a poor-adherent part, the sealing portion is not fully compressed, and can fill the corresponding gap. The transcatheter valve system can effectively reduce the conveying diameter, can effectively select different perivalvular leakage-proof portion designs according to the lesion characteristics of different implanting points, and can greatly lower the occurrence rate of perivalvular leakage after the transcatheter valve is implanted.
Owner:BEIHANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products